nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—pancreatic cancer	0.371	1	CiPCiCtD
Gemcitabine—kidney cancer—pancreatic cancer	0.2	1	CtDrD
Gemcitabine—SLC29A1—pancreatic cancer	0.155	0.737	CbGaD
Gemcitabine—TYMS—pancreatic cancer	0.055	0.263	CbGaD
Gemcitabine—SLC29A1—Fluorouracil—pancreatic cancer	0.0362	0.299	CbGbCtD
Gemcitabine—TYMS—Fluorouracil—pancreatic cancer	0.0336	0.277	CbGbCtD
Gemcitabine—ABCC10—Docetaxel—pancreatic cancer	0.0211	0.174	CbGbCtD
Gemcitabine—ABCC10—Doxorubicin—pancreatic cancer	0.0158	0.13	CbGbCtD
Gemcitabine—ABCB1—Tamoxifen—pancreatic cancer	0.0035	0.0289	CbGbCtD
Gemcitabine—ABCB1—Erlotinib—pancreatic cancer	0.00298	0.0245	CbGbCtD
Gemcitabine—ABCB1—Irinotecan—pancreatic cancer	0.00269	0.0222	CbGbCtD
Gemcitabine—ABCB1—Docetaxel—pancreatic cancer	0.00197	0.0162	CbGbCtD
Gemcitabine—ABCB1—Sunitinib—pancreatic cancer	0.00196	0.0162	CbGbCtD
Gemcitabine—ABCB1—Doxorubicin—pancreatic cancer	0.00147	0.0121	CbGbCtD
Gemcitabine—SLC28A3—islet of Langerhans—pancreatic cancer	0.000754	0.0851	CbGeAlD
Gemcitabine—Zalcitabine—SLC29A1—pancreatic cancer	0.000745	0.598	CrCbGaD
Gemcitabine—SLC28A1—digestive system—pancreatic cancer	0.000741	0.0836	CbGeAlD
Gemcitabine—CMPK1—islet of Langerhans—pancreatic cancer	0.000656	0.074	CbGeAlD
Gemcitabine—POLD1—pancreas—pancreatic cancer	0.000578	0.0652	CbGeAlD
Gemcitabine—SLC28A3—pancreas—pancreatic cancer	0.00053	0.0598	CbGeAlD
Gemcitabine—Cytarabine—SLC29A1—pancreatic cancer	0.0005	0.402	CrCbGaD
Gemcitabine—POLD1—digestive system—pancreatic cancer	0.000494	0.0557	CbGeAlD
Gemcitabine—CMPK1—pancreas—pancreatic cancer	0.000461	0.052	CbGeAlD
Gemcitabine—SLC28A3—digestive system—pancreatic cancer	0.000453	0.0511	CbGeAlD
Gemcitabine—RRM1—islet of Langerhans—pancreatic cancer	0.00042	0.0474	CbGeAlD
Gemcitabine—CMPK1—digestive system—pancreatic cancer	0.000394	0.0444	CbGeAlD
Gemcitabine—POLE—digestive system—pancreatic cancer	0.000369	0.0416	CbGeAlD
Gemcitabine—SLC29A1—islet of Langerhans—pancreatic cancer	0.000342	0.0386	CbGeAlD
Gemcitabine—DCK—islet of Langerhans—pancreatic cancer	0.000327	0.0368	CbGeAlD
Gemcitabine—RRM2—digestive system—pancreatic cancer	0.000304	0.0343	CbGeAlD
Gemcitabine—RRM2—Gefitinib—Erlotinib—pancreatic cancer	0.000301	0.298	CbGdCrCtD
Gemcitabine—RRM1—pancreas—pancreatic cancer	0.000296	0.0333	CbGeAlD
Gemcitabine—DCK—Topotecan—Irinotecan—pancreatic cancer	0.000254	0.251	CbGdCrCtD
Gemcitabine—RRM1—digestive system—pancreatic cancer	0.000252	0.0285	CbGeAlD
Gemcitabine—SLC29A1—pancreas—pancreatic cancer	0.00024	0.0271	CbGeAlD
Gemcitabine—DCK—pancreas—pancreatic cancer	0.00023	0.0259	CbGeAlD
Gemcitabine—TYMS—digestive system—pancreatic cancer	0.000229	0.0258	CbGeAlD
Gemcitabine—SLC29A1—digestive system—pancreatic cancer	0.000205	0.0232	CbGeAlD
Gemcitabine—DCK—digestive system—pancreatic cancer	0.000196	0.0221	CbGeAlD
Gemcitabine—ABCC10—digestive system—pancreatic cancer	0.000187	0.0211	CbGeAlD
Gemcitabine—TYMS—Paclitaxel—Docetaxel—pancreatic cancer	0.000134	0.133	CbGdCrCtD
Gemcitabine—TYMS—Gefitinib—Erlotinib—pancreatic cancer	0.000129	0.127	CbGdCrCtD
Gemcitabine—ABCB1—islet of Langerhans—pancreatic cancer	8.98e-05	0.0101	CbGeAlD
Gemcitabine—DCK—Clomifene—Tamoxifen—pancreatic cancer	7.82e-05	0.0773	CbGdCrCtD
Gemcitabine—ABCB1—pancreas—pancreatic cancer	6.32e-05	0.00713	CbGeAlD
Gemcitabine—DCK—Doxorubicin—Epirubicin—pancreatic cancer	5.97e-05	0.059	CbGdCrCtD
Gemcitabine—DCK—Epirubicin—Doxorubicin—pancreatic cancer	5.52e-05	0.0546	CbGdCrCtD
Gemcitabine—ABCB1—digestive system—pancreatic cancer	5.39e-05	0.00609	CbGeAlD
Gemcitabine—Hypotension—Fluorouracil—pancreatic cancer	2.94e-05	0.000599	CcSEcCtD
Gemcitabine—Rash—Tamoxifen—pancreatic cancer	2.94e-05	0.000598	CcSEcCtD
Gemcitabine—Dermatitis—Tamoxifen—pancreatic cancer	2.94e-05	0.000598	CcSEcCtD
Gemcitabine—Vomiting—Erlotinib—pancreatic cancer	2.93e-05	0.000597	CcSEcCtD
Gemcitabine—Dyspnoea—Irinotecan—pancreatic cancer	2.93e-05	0.000597	CcSEcCtD
Gemcitabine—Somnolence—Irinotecan—pancreatic cancer	2.93e-05	0.000595	CcSEcCtD
Gemcitabine—Blood creatinine increased—Epirubicin—pancreatic cancer	2.92e-05	0.000595	CcSEcCtD
Gemcitabine—Headache—Tamoxifen—pancreatic cancer	2.92e-05	0.000594	CcSEcCtD
Gemcitabine—Rash—Erlotinib—pancreatic cancer	2.91e-05	0.000592	CcSEcCtD
Gemcitabine—Dermatitis—Erlotinib—pancreatic cancer	2.91e-05	0.000591	CcSEcCtD
Gemcitabine—Angiopathy—Docetaxel—pancreatic cancer	2.9e-05	0.000591	CcSEcCtD
Gemcitabine—Immune system disorder—Docetaxel—pancreatic cancer	2.89e-05	0.000588	CcSEcCtD
Gemcitabine—Headache—Erlotinib—pancreatic cancer	2.89e-05	0.000588	CcSEcCtD
Gemcitabine—Mediastinal disorder—Docetaxel—pancreatic cancer	2.89e-05	0.000587	CcSEcCtD
Gemcitabine—Liver function test abnormal—Epirubicin—pancreatic cancer	2.88e-05	0.000586	CcSEcCtD
Gemcitabine—Chills—Docetaxel—pancreatic cancer	2.87e-05	0.000584	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	2.87e-05	0.000584	CcSEcCtD
Gemcitabine—Asthenia—Sunitinib—pancreatic cancer	2.87e-05	0.000583	CcSEcCtD
Gemcitabine—Decreased appetite—Irinotecan—pancreatic cancer	2.86e-05	0.000582	CcSEcCtD
Gemcitabine—Arrhythmia—Docetaxel—pancreatic cancer	2.86e-05	0.000582	CcSEcCtD
Gemcitabine—Insomnia—Fluorouracil—pancreatic cancer	2.85e-05	0.00058	CcSEcCtD
Gemcitabine—Hypokalaemia—Epirubicin—pancreatic cancer	2.84e-05	0.000578	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	2.84e-05	0.000578	CcSEcCtD
Gemcitabine—Fatigue—Irinotecan—pancreatic cancer	2.84e-05	0.000577	CcSEcCtD
Gemcitabine—Paraesthesia—Fluorouracil—pancreatic cancer	2.83e-05	0.000576	CcSEcCtD
Gemcitabine—Alopecia—Docetaxel—pancreatic cancer	2.83e-05	0.000575	CcSEcCtD
Gemcitabine—Pruritus—Sunitinib—pancreatic cancer	2.83e-05	0.000575	CcSEcCtD
Gemcitabine—Pain—Irinotecan—pancreatic cancer	2.81e-05	0.000572	CcSEcCtD
Gemcitabine—Constipation—Irinotecan—pancreatic cancer	2.81e-05	0.000572	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	2.81e-05	0.000572	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	2.81e-05	0.000572	CcSEcCtD
Gemcitabine—Dyspnoea—Fluorouracil—pancreatic cancer	2.81e-05	0.000571	CcSEcCtD
Gemcitabine—Somnolence—Fluorouracil—pancreatic cancer	2.8e-05	0.00057	CcSEcCtD
Gemcitabine—Face oedema—Doxorubicin—pancreatic cancer	2.79e-05	0.000567	CcSEcCtD
Gemcitabine—Erythema—Docetaxel—pancreatic cancer	2.79e-05	0.000567	CcSEcCtD
Gemcitabine—Nausea—Tamoxifen—pancreatic cancer	2.77e-05	0.000563	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	2.75e-05	0.00056	CcSEcCtD
Gemcitabine—Nausea—Erlotinib—pancreatic cancer	2.74e-05	0.000557	CcSEcCtD
Gemcitabine—Decreased appetite—Fluorouracil—pancreatic cancer	2.74e-05	0.000557	CcSEcCtD
Gemcitabine—Diarrhoea—Sunitinib—pancreatic cancer	2.73e-05	0.000556	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	2.72e-05	0.000553	CcSEcCtD
Gemcitabine—Feeling abnormal—Irinotecan—pancreatic cancer	2.71e-05	0.000552	CcSEcCtD
Gemcitabine—Blood creatinine increased—Doxorubicin—pancreatic cancer	2.71e-05	0.00055	CcSEcCtD
Gemcitabine—Influenza—Epirubicin—pancreatic cancer	2.7e-05	0.000549	CcSEcCtD
Gemcitabine—Back pain—Docetaxel—pancreatic cancer	2.7e-05	0.000548	CcSEcCtD
Gemcitabine—Pain—Fluorouracil—pancreatic cancer	2.69e-05	0.000548	CcSEcCtD
Gemcitabine—Liver function test abnormal—Doxorubicin—pancreatic cancer	2.67e-05	0.000542	CcSEcCtD
Gemcitabine—Hypokalaemia—Doxorubicin—pancreatic cancer	2.63e-05	0.000535	CcSEcCtD
Gemcitabine—Body temperature increased—Irinotecan—pancreatic cancer	2.6e-05	0.000529	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	2.6e-05	0.000529	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	2.6e-05	0.000529	CcSEcCtD
Gemcitabine—Feeling abnormal—Fluorouracil—pancreatic cancer	2.6e-05	0.000528	CcSEcCtD
Gemcitabine—Anaemia—Docetaxel—pancreatic cancer	2.58e-05	0.000524	CcSEcCtD
Gemcitabine—Pancytopenia—Epirubicin—pancreatic cancer	2.56e-05	0.000521	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	2.55e-05	0.000518	CcSEcCtD
Gemcitabine—Vomiting—Sunitinib—pancreatic cancer	2.54e-05	0.000517	CcSEcCtD
Gemcitabine—Neutropenia—Epirubicin—pancreatic cancer	2.52e-05	0.000513	CcSEcCtD
Gemcitabine—Rash—Sunitinib—pancreatic cancer	2.52e-05	0.000512	CcSEcCtD
Gemcitabine—Dermatitis—Sunitinib—pancreatic cancer	2.52e-05	0.000512	CcSEcCtD
Gemcitabine—Headache—Sunitinib—pancreatic cancer	2.5e-05	0.000509	CcSEcCtD
Gemcitabine—Influenza—Doxorubicin—pancreatic cancer	2.5e-05	0.000508	CcSEcCtD
Gemcitabine—Leukopenia—Docetaxel—pancreatic cancer	2.49e-05	0.000507	CcSEcCtD
Gemcitabine—Body temperature increased—Fluorouracil—pancreatic cancer	2.49e-05	0.000507	CcSEcCtD
Gemcitabine—Hyperglycaemia—Epirubicin—pancreatic cancer	2.43e-05	0.000495	CcSEcCtD
Gemcitabine—Cough—Docetaxel—pancreatic cancer	2.43e-05	0.000495	CcSEcCtD
Gemcitabine—Pneumonia—Epirubicin—pancreatic cancer	2.42e-05	0.000492	CcSEcCtD
Gemcitabine—Hypertension—Docetaxel—pancreatic cancer	2.41e-05	0.000489	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	2.38e-05	0.000485	CcSEcCtD
Gemcitabine—Arthralgia—Docetaxel—pancreatic cancer	2.37e-05	0.000483	CcSEcCtD
Gemcitabine—Chest pain—Docetaxel—pancreatic cancer	2.37e-05	0.000483	CcSEcCtD
Gemcitabine—Myalgia—Docetaxel—pancreatic cancer	2.37e-05	0.000483	CcSEcCtD
Gemcitabine—Nausea—Sunitinib—pancreatic cancer	2.37e-05	0.000483	CcSEcCtD
Gemcitabine—Pancytopenia—Doxorubicin—pancreatic cancer	2.37e-05	0.000482	CcSEcCtD
Gemcitabine—Renal failure—Epirubicin—pancreatic cancer	2.36e-05	0.000481	CcSEcCtD
Gemcitabine—Asthenia—Irinotecan—pancreatic cancer	2.36e-05	0.00048	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Epirubicin—pancreatic cancer	2.36e-05	0.00048	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	2.36e-05	0.000479	CcSEcCtD
Gemcitabine—Stomatitis—Epirubicin—pancreatic cancer	2.34e-05	0.000477	CcSEcCtD
Gemcitabine—Neutropenia—Doxorubicin—pancreatic cancer	2.33e-05	0.000475	CcSEcCtD
Gemcitabine—Sweating—Epirubicin—pancreatic cancer	2.31e-05	0.000469	CcSEcCtD
Gemcitabine—Haematuria—Epirubicin—pancreatic cancer	2.29e-05	0.000467	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Epirubicin—pancreatic cancer	2.27e-05	0.000463	CcSEcCtD
Gemcitabine—Anaphylactic shock—Docetaxel—pancreatic cancer	2.27e-05	0.000463	CcSEcCtD
Gemcitabine—Oedema—Docetaxel—pancreatic cancer	2.27e-05	0.000463	CcSEcCtD
Gemcitabine—Infection—Docetaxel—pancreatic cancer	2.26e-05	0.00046	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—pancreatic cancer	2.25e-05	0.000458	CcSEcCtD
Gemcitabine—Diarrhoea—Irinotecan—pancreatic cancer	2.25e-05	0.000458	CcSEcCtD
Gemcitabine—Agranulocytosis—Epirubicin—pancreatic cancer	2.24e-05	0.000457	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—pancreatic cancer	2.24e-05	0.000455	CcSEcCtD
Gemcitabine—Nervous system disorder—Docetaxel—pancreatic cancer	2.23e-05	0.000454	CcSEcCtD
Gemcitabine—Pruritus—Fluorouracil—pancreatic cancer	2.23e-05	0.000453	CcSEcCtD
Gemcitabine—Thrombocytopenia—Docetaxel—pancreatic cancer	2.23e-05	0.000453	CcSEcCtD
Gemcitabine—Skin disorder—Docetaxel—pancreatic cancer	2.21e-05	0.000449	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	2.21e-05	0.000449	CcSEcCtD
Gemcitabine—Renal failure—Doxorubicin—pancreatic cancer	2.19e-05	0.000445	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	2.18e-05	0.000444	CcSEcCtD
Gemcitabine—Haemoglobin—Epirubicin—pancreatic cancer	2.17e-05	0.000441	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—pancreatic cancer	2.17e-05	0.000441	CcSEcCtD
Gemcitabine—Anorexia—Docetaxel—pancreatic cancer	2.17e-05	0.000441	CcSEcCtD
Gemcitabine—Rhinitis—Epirubicin—pancreatic cancer	2.16e-05	0.00044	CcSEcCtD
Gemcitabine—Haemorrhage—Epirubicin—pancreatic cancer	2.16e-05	0.000439	CcSEcCtD
Gemcitabine—Diarrhoea—Fluorouracil—pancreatic cancer	2.16e-05	0.000439	CcSEcCtD
Gemcitabine—Pharyngitis—Epirubicin—pancreatic cancer	2.14e-05	0.000436	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—pancreatic cancer	2.13e-05	0.000434	CcSEcCtD
Gemcitabine—Urinary tract disorder—Epirubicin—pancreatic cancer	2.13e-05	0.000434	CcSEcCtD
Gemcitabine—Oedema peripheral—Epirubicin—pancreatic cancer	2.13e-05	0.000433	CcSEcCtD
Gemcitabine—Hypotension—Docetaxel—pancreatic cancer	2.13e-05	0.000432	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—pancreatic cancer	2.12e-05	0.000432	CcSEcCtD
Gemcitabine—Connective tissue disorder—Epirubicin—pancreatic cancer	2.12e-05	0.000432	CcSEcCtD
Gemcitabine—Urethral disorder—Epirubicin—pancreatic cancer	2.12e-05	0.000431	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	2.1e-05	0.000428	CcSEcCtD
Gemcitabine—Vomiting—Irinotecan—pancreatic cancer	2.09e-05	0.000426	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—pancreatic cancer	2.08e-05	0.000422	CcSEcCtD
Gemcitabine—Rash—Irinotecan—pancreatic cancer	2.07e-05	0.000422	CcSEcCtD
Gemcitabine—Dermatitis—Irinotecan—pancreatic cancer	2.07e-05	0.000422	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	2.07e-05	0.000422	CcSEcCtD
Gemcitabine—Headache—Irinotecan—pancreatic cancer	2.06e-05	0.000419	CcSEcCtD
Gemcitabine—Insomnia—Docetaxel—pancreatic cancer	2.06e-05	0.000418	CcSEcCtD
Gemcitabine—Paraesthesia—Docetaxel—pancreatic cancer	2.04e-05	0.000415	CcSEcCtD
Gemcitabine—Erythema multiforme—Epirubicin—pancreatic cancer	2.04e-05	0.000415	CcSEcCtD
Gemcitabine—Dyspnoea—Docetaxel—pancreatic cancer	2.03e-05	0.000412	CcSEcCtD
Gemcitabine—Somnolence—Docetaxel—pancreatic cancer	2.02e-05	0.000411	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—pancreatic cancer	2.01e-05	0.000408	CcSEcCtD
Gemcitabine—Cardiac disorder—Epirubicin—pancreatic cancer	2e-05	0.000408	CcSEcCtD
Gemcitabine—Vomiting—Fluorouracil—pancreatic cancer	2e-05	0.000408	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—pancreatic cancer	2e-05	0.000407	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—pancreatic cancer	2e-05	0.000406	CcSEcCtD
Gemcitabine—Rash—Fluorouracil—pancreatic cancer	1.99e-05	0.000404	CcSEcCtD
Gemcitabine—Dermatitis—Fluorouracil—pancreatic cancer	1.99e-05	0.000404	CcSEcCtD
Gemcitabine—Pharyngitis—Doxorubicin—pancreatic cancer	1.98e-05	0.000403	CcSEcCtD
Gemcitabine—Decreased appetite—Docetaxel—pancreatic cancer	1.98e-05	0.000402	CcSEcCtD
Gemcitabine—Headache—Fluorouracil—pancreatic cancer	1.97e-05	0.000402	CcSEcCtD
Gemcitabine—Urinary tract disorder—Doxorubicin—pancreatic cancer	1.97e-05	0.000401	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—pancreatic cancer	1.97e-05	0.0004	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	1.96e-05	0.000399	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—pancreatic cancer	1.96e-05	0.000399	CcSEcCtD
Gemcitabine—Fatigue—Docetaxel—pancreatic cancer	1.96e-05	0.000399	CcSEcCtD
Gemcitabine—Angiopathy—Epirubicin—pancreatic cancer	1.96e-05	0.000398	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—pancreatic cancer	1.96e-05	0.000398	CcSEcCtD
Gemcitabine—Nausea—Irinotecan—pancreatic cancer	1.95e-05	0.000398	CcSEcCtD
Gemcitabine—Immune system disorder—Epirubicin—pancreatic cancer	1.95e-05	0.000397	CcSEcCtD
Gemcitabine—Mediastinal disorder—Epirubicin—pancreatic cancer	1.95e-05	0.000396	CcSEcCtD
Gemcitabine—Constipation—Docetaxel—pancreatic cancer	1.95e-05	0.000396	CcSEcCtD
Gemcitabine—Pain—Docetaxel—pancreatic cancer	1.95e-05	0.000396	CcSEcCtD
Gemcitabine—Chills—Epirubicin—pancreatic cancer	1.94e-05	0.000394	CcSEcCtD
Gemcitabine—Arrhythmia—Epirubicin—pancreatic cancer	1.93e-05	0.000392	CcSEcCtD
Gemcitabine—Alopecia—Epirubicin—pancreatic cancer	1.91e-05	0.000388	CcSEcCtD
Gemcitabine—Erythema multiforme—Doxorubicin—pancreatic cancer	1.89e-05	0.000384	CcSEcCtD
Gemcitabine—Erythema—Epirubicin—pancreatic cancer	1.88e-05	0.000382	CcSEcCtD
Gemcitabine—Feeling abnormal—Docetaxel—pancreatic cancer	1.87e-05	0.000381	CcSEcCtD
Gemcitabine—Nausea—Fluorouracil—pancreatic cancer	1.87e-05	0.000381	CcSEcCtD
Gemcitabine—Cardiac disorder—Doxorubicin—pancreatic cancer	1.85e-05	0.000377	CcSEcCtD
Gemcitabine—Back pain—Epirubicin—pancreatic cancer	1.82e-05	0.00037	CcSEcCtD
Gemcitabine—Angiopathy—Doxorubicin—pancreatic cancer	1.81e-05	0.000369	CcSEcCtD
Gemcitabine—Immune system disorder—Doxorubicin—pancreatic cancer	1.8e-05	0.000367	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—pancreatic cancer	1.8e-05	0.000366	CcSEcCtD
Gemcitabine—Body temperature increased—Docetaxel—pancreatic cancer	1.8e-05	0.000366	CcSEcCtD
Gemcitabine—Chills—Doxorubicin—pancreatic cancer	1.79e-05	0.000365	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—pancreatic cancer	1.78e-05	0.000363	CcSEcCtD
Gemcitabine—Alopecia—Doxorubicin—pancreatic cancer	1.77e-05	0.000359	CcSEcCtD
Gemcitabine—Ill-defined disorder—Epirubicin—pancreatic cancer	1.74e-05	0.000355	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—pancreatic cancer	1.74e-05	0.000354	CcSEcCtD
Gemcitabine—Anaemia—Epirubicin—pancreatic cancer	1.74e-05	0.000353	CcSEcCtD
Gemcitabine—Malaise—Epirubicin—pancreatic cancer	1.7e-05	0.000345	CcSEcCtD
Gemcitabine—Leukopenia—Epirubicin—pancreatic cancer	1.68e-05	0.000342	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—pancreatic cancer	1.68e-05	0.000342	CcSEcCtD
Gemcitabine—Cough—Epirubicin—pancreatic cancer	1.64e-05	0.000334	CcSEcCtD
Gemcitabine—Asthenia—Docetaxel—pancreatic cancer	1.63e-05	0.000332	CcSEcCtD
Gemcitabine—Hypertension—Epirubicin—pancreatic cancer	1.62e-05	0.00033	CcSEcCtD
Gemcitabine—Ill-defined disorder—Doxorubicin—pancreatic cancer	1.61e-05	0.000328	CcSEcCtD
Gemcitabine—Pruritus—Docetaxel—pancreatic cancer	1.61e-05	0.000327	CcSEcCtD
Gemcitabine—Anaemia—Doxorubicin—pancreatic cancer	1.61e-05	0.000327	CcSEcCtD
Gemcitabine—Arthralgia—Epirubicin—pancreatic cancer	1.6e-05	0.000326	CcSEcCtD
Gemcitabine—Chest pain—Epirubicin—pancreatic cancer	1.6e-05	0.000326	CcSEcCtD
Gemcitabine—Myalgia—Epirubicin—pancreatic cancer	1.6e-05	0.000326	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.59e-05	0.000323	CcSEcCtD
Gemcitabine—Discomfort—Epirubicin—pancreatic cancer	1.58e-05	0.000322	CcSEcCtD
Gemcitabine—Malaise—Doxorubicin—pancreatic cancer	1.57e-05	0.000319	CcSEcCtD
Gemcitabine—Leukopenia—Doxorubicin—pancreatic cancer	1.56e-05	0.000317	CcSEcCtD
Gemcitabine—Diarrhoea—Docetaxel—pancreatic cancer	1.56e-05	0.000317	CcSEcCtD
Gemcitabine—Anaphylactic shock—Epirubicin—pancreatic cancer	1.53e-05	0.000312	CcSEcCtD
Gemcitabine—Oedema—Epirubicin—pancreatic cancer	1.53e-05	0.000312	CcSEcCtD
Gemcitabine—Infection—Epirubicin—pancreatic cancer	1.52e-05	0.00031	CcSEcCtD
Gemcitabine—Cough—Doxorubicin—pancreatic cancer	1.52e-05	0.000309	CcSEcCtD
Gemcitabine—Nervous system disorder—Epirubicin—pancreatic cancer	1.5e-05	0.000306	CcSEcCtD
Gemcitabine—Thrombocytopenia—Epirubicin—pancreatic cancer	1.5e-05	0.000306	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—pancreatic cancer	1.5e-05	0.000305	CcSEcCtD
Gemcitabine—Skin disorder—Epirubicin—pancreatic cancer	1.49e-05	0.000303	CcSEcCtD
Gemcitabine—Hyperhidrosis—Epirubicin—pancreatic cancer	1.48e-05	0.000302	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—pancreatic cancer	1.48e-05	0.000301	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—pancreatic cancer	1.48e-05	0.000301	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—pancreatic cancer	1.48e-05	0.000301	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.47e-05	0.000299	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—pancreatic cancer	1.46e-05	0.000298	CcSEcCtD
Gemcitabine—Anorexia—Epirubicin—pancreatic cancer	1.46e-05	0.000297	CcSEcCtD
Gemcitabine—Vomiting—Docetaxel—pancreatic cancer	1.45e-05	0.000294	CcSEcCtD
Gemcitabine—Rash—Docetaxel—pancreatic cancer	1.43e-05	0.000292	CcSEcCtD
Gemcitabine—Hypotension—Epirubicin—pancreatic cancer	1.43e-05	0.000292	CcSEcCtD
Gemcitabine—Dermatitis—Docetaxel—pancreatic cancer	1.43e-05	0.000291	CcSEcCtD
Gemcitabine—Headache—Docetaxel—pancreatic cancer	1.42e-05	0.00029	CcSEcCtD
Gemcitabine—Oedema—Doxorubicin—pancreatic cancer	1.42e-05	0.000289	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.42e-05	0.000289	CcSEcCtD
Gemcitabine—Infection—Doxorubicin—pancreatic cancer	1.41e-05	0.000287	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.4e-05	0.000284	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—pancreatic cancer	1.39e-05	0.000283	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.39e-05	0.000283	CcSEcCtD
Gemcitabine—Insomnia—Epirubicin—pancreatic cancer	1.39e-05	0.000282	CcSEcCtD
Gemcitabine—Skin disorder—Doxorubicin—pancreatic cancer	1.38e-05	0.00028	CcSEcCtD
Gemcitabine—Paraesthesia—Epirubicin—pancreatic cancer	1.38e-05	0.00028	CcSEcCtD
Gemcitabine—Hyperhidrosis—Doxorubicin—pancreatic cancer	1.37e-05	0.000279	CcSEcCtD
Gemcitabine—Dyspnoea—Epirubicin—pancreatic cancer	1.37e-05	0.000278	CcSEcCtD
Gemcitabine—Somnolence—Epirubicin—pancreatic cancer	1.36e-05	0.000277	CcSEcCtD
Gemcitabine—Anorexia—Doxorubicin—pancreatic cancer	1.35e-05	0.000275	CcSEcCtD
Gemcitabine—Nausea—Docetaxel—pancreatic cancer	1.35e-05	0.000275	CcSEcCtD
Gemcitabine—Decreased appetite—Epirubicin—pancreatic cancer	1.33e-05	0.000271	CcSEcCtD
Gemcitabine—Hypotension—Doxorubicin—pancreatic cancer	1.33e-05	0.00027	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.32e-05	0.000269	CcSEcCtD
Gemcitabine—Fatigue—Epirubicin—pancreatic cancer	1.32e-05	0.000269	CcSEcCtD
Gemcitabine—Constipation—Epirubicin—pancreatic cancer	1.31e-05	0.000267	CcSEcCtD
Gemcitabine—Pain—Epirubicin—pancreatic cancer	1.31e-05	0.000267	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.29e-05	0.000263	CcSEcCtD
Gemcitabine—Insomnia—Doxorubicin—pancreatic cancer	1.28e-05	0.000261	CcSEcCtD
Gemcitabine—Paraesthesia—Doxorubicin—pancreatic cancer	1.27e-05	0.000259	CcSEcCtD
Gemcitabine—Dyspnoea—Doxorubicin—pancreatic cancer	1.27e-05	0.000257	CcSEcCtD
Gemcitabine—Feeling abnormal—Epirubicin—pancreatic cancer	1.26e-05	0.000257	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—pancreatic cancer	1.26e-05	0.000257	CcSEcCtD
Gemcitabine—Decreased appetite—Doxorubicin—pancreatic cancer	1.23e-05	0.000251	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.23e-05	0.000249	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—pancreatic cancer	1.22e-05	0.000249	CcSEcCtD
Gemcitabine—Constipation—Doxorubicin—pancreatic cancer	1.21e-05	0.000247	CcSEcCtD
Gemcitabine—Pain—Doxorubicin—pancreatic cancer	1.21e-05	0.000247	CcSEcCtD
Gemcitabine—Body temperature increased—Epirubicin—pancreatic cancer	1.21e-05	0.000247	CcSEcCtD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	1.2e-05	0.00032	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—MYC—pancreatic cancer	1.2e-05	0.000319	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—APOE—pancreatic cancer	1.19e-05	0.000318	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TYMP—pancreatic cancer	1.17e-05	0.000312	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CD44—pancreatic cancer	1.17e-05	0.000312	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Doxorubicin—pancreatic cancer	1.17e-05	0.000238	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.16e-05	0.000309	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TERT—pancreatic cancer	1.15e-05	0.000306	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SLC2A2—pancreatic cancer	1.15e-05	0.000305	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TERT—pancreatic cancer	1.14e-05	0.000304	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GCG—pancreatic cancer	1.12e-05	0.000299	CbGpPWpGaD
Gemcitabine—Body temperature increased—Doxorubicin—pancreatic cancer	1.12e-05	0.000228	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.11e-05	0.000296	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—MYC—pancreatic cancer	1.11e-05	0.000296	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TERT—pancreatic cancer	1.1e-05	0.000294	CbGpPWpGaD
Gemcitabine—Asthenia—Epirubicin—pancreatic cancer	1.1e-05	0.000224	CcSEcCtD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	1.1e-05	0.000293	CbGpPWpGaD
Gemcitabine—Pruritus—Epirubicin—pancreatic cancer	1.09e-05	0.000221	CcSEcCtD
Gemcitabine—TYMS—Metabolism—PRSS1—pancreatic cancer	1.08e-05	0.000289	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CG—pancreatic cancer	1.08e-05	0.000287	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	1.08e-05	0.000287	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.08e-05	0.000287	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—MYC—pancreatic cancer	1.06e-05	0.000283	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—STK11—pancreatic cancer	1.06e-05	0.000281	CbGpPWpGaD
Gemcitabine—Diarrhoea—Epirubicin—pancreatic cancer	1.05e-05	0.000214	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.05e-05	0.000279	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PPARG—pancreatic cancer	1.04e-05	0.000277	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.04e-05	0.000277	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.04e-05	0.000276	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.03e-05	0.000275	CbGpPWpGaD
Gemcitabine—Asthenia—Doxorubicin—pancreatic cancer	1.02e-05	0.000207	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.01e-05	0.00027	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GLP1R—pancreatic cancer	1.01e-05	0.000269	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—TYMS—pancreatic cancer	1.01e-05	0.000269	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1e-05	0.000268	CbGpPWpGaD
Gemcitabine—Pruritus—Doxorubicin—pancreatic cancer	1e-05	0.000204	CcSEcCtD
Gemcitabine—POLD1—Metabolism—GLP1R—pancreatic cancer	1e-05	0.000268	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—RB1—pancreatic cancer	1e-05	0.000266	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	9.95e-06	0.000265	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—DPYD—pancreatic cancer	9.94e-06	0.000265	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—RB1—pancreatic cancer	9.94e-06	0.000265	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—DPYD—pancreatic cancer	9.88e-06	0.000263	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	9.85e-06	0.000262	CbGpPWpGaD
Gemcitabine—Vomiting—Epirubicin—pancreatic cancer	9.75e-06	0.000198	CcSEcCtD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	9.73e-06	0.000259	CbGpPWpGaD
Gemcitabine—Diarrhoea—Doxorubicin—pancreatic cancer	9.71e-06	0.000198	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	9.7e-06	0.000258	CbGpPWpGaD
Gemcitabine—Rash—Epirubicin—pancreatic cancer	9.67e-06	0.000197	CcSEcCtD
Gemcitabine—Dermatitis—Epirubicin—pancreatic cancer	9.66e-06	0.000197	CcSEcCtD
Gemcitabine—Headache—Epirubicin—pancreatic cancer	9.61e-06	0.000195	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—RB1—pancreatic cancer	9.6e-06	0.000256	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—BRCA2—pancreatic cancer	9.48e-06	0.000253	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CD—pancreatic cancer	9.48e-06	0.000253	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GLP1R—pancreatic cancer	9.44e-06	0.000252	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SLC2A2—pancreatic cancer	9.43e-06	0.000251	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ARG2—pancreatic cancer	9.4e-06	0.00025	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	9.39e-06	0.00025	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SLC2A2—pancreatic cancer	9.38e-06	0.00025	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—PTEN—pancreatic cancer	9.31e-06	0.000248	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—DPYD—pancreatic cancer	9.29e-06	0.000247	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	9.14e-06	0.000244	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—RB1—pancreatic cancer	9.14e-06	0.000244	CbGpPWpGaD
Gemcitabine—Nausea—Epirubicin—pancreatic cancer	9.11e-06	0.000185	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—BRCA2—pancreatic cancer	9.08e-06	0.000242	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—TYMS—pancreatic cancer	9.08e-06	0.000242	CbGpPWpGaD
Gemcitabine—Vomiting—Doxorubicin—pancreatic cancer	9.03e-06	0.000184	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—TYMS—pancreatic cancer	9.02e-06	0.00024	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	8.99e-06	0.00024	CbGpPWpGaD
Gemcitabine—Rash—Doxorubicin—pancreatic cancer	8.95e-06	0.000182	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—pancreatic cancer	8.94e-06	0.000182	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—RB1—pancreatic cancer	8.94e-06	0.000238	CbGpPWpGaD
Gemcitabine—Headache—Doxorubicin—pancreatic cancer	8.89e-06	0.000181	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—RB1—pancreatic cancer	8.88e-06	0.000237	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CD44—pancreatic cancer	8.87e-06	0.000236	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SLC2A2—pancreatic cancer	8.81e-06	0.000235	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	8.79e-06	0.000234	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	8.76e-06	0.000233	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	8.73e-06	0.000233	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—RB1—pancreatic cancer	8.58e-06	0.000229	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	8.51e-06	0.000227	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GCG—pancreatic cancer	8.5e-06	0.000227	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	8.43e-06	0.000225	CbGpPWpGaD
Gemcitabine—Nausea—Doxorubicin—pancreatic cancer	8.43e-06	0.000172	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	8.41e-06	0.000224	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	8.39e-06	0.000224	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	8.36e-06	0.000223	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CB—pancreatic cancer	8.26e-06	0.00022	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	8.23e-06	0.000219	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TYMP—pancreatic cancer	8.21e-06	0.000219	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—pancreatic cancer	8.19e-06	0.000218	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	8.06e-06	0.000215	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	8.04e-06	0.000214	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—STK11—pancreatic cancer	8e-06	0.000213	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	7.88e-06	0.00021	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—pancreatic cancer	7.86e-06	0.000209	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TERT—pancreatic cancer	7.86e-06	0.000209	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	7.84e-06	0.000209	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—pancreatic cancer	7.81e-06	0.000208	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	7.77e-06	0.000207	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—pancreatic cancer	7.54e-06	0.000201	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TERT—pancreatic cancer	7.53e-06	0.000201	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	7.51e-06	0.0002	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	7.45e-06	0.000198	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—pancreatic cancer	7.42e-06	0.000198	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	7.39e-06	0.000197	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—APOE—pancreatic cancer	7.38e-06	0.000197	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—pancreatic cancer	7.38e-06	0.000197	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CD44—pancreatic cancer	7.3e-06	0.000195	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CD44—pancreatic cancer	7.26e-06	0.000193	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	7.16e-06	0.000191	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	7.14e-06	0.00019	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTEN—pancreatic cancer	7.14e-06	0.00019	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—pancreatic cancer	7.13e-06	0.00019	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GCG—pancreatic cancer	7e-06	0.000187	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GCG—pancreatic cancer	6.96e-06	0.000185	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	6.91e-06	0.000184	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—TYMS—pancreatic cancer	6.88e-06	0.000183	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	6.84e-06	0.000182	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—RB1—pancreatic cancer	6.84e-06	0.000182	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CD44—pancreatic cancer	6.83e-06	0.000182	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	6.74e-06	0.00018	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CG—pancreatic cancer	6.66e-06	0.000177	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—pancreatic cancer	6.64e-06	0.000177	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GLP1R—pancreatic cancer	6.62e-06	0.000176	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	6.62e-06	0.000176	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—pancreatic cancer	6.6e-06	0.000176	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—STK11—pancreatic cancer	6.58e-06	0.000175	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RB1—pancreatic cancer	6.55e-06	0.000175	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—STK11—pancreatic cancer	6.54e-06	0.000174	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GCG—pancreatic cancer	6.54e-06	0.000174	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—DPYD—pancreatic cancer	6.51e-06	0.000174	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	6.47e-06	0.000172	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	6.46e-06	0.000172	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARG—pancreatic cancer	6.43e-06	0.000171	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—pancreatic cancer	6.37e-06	0.00017	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—pancreatic cancer	6.35e-06	0.000169	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	6.32e-06	0.000169	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	6.27e-06	0.000167	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC2A2—pancreatic cancer	6.18e-06	0.000165	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	6.16e-06	0.000164	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—STK11—pancreatic cancer	6.15e-06	0.000164	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—RB1—pancreatic cancer	6.11e-06	0.000163	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	6.01e-06	0.00016	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—pancreatic cancer	5.95e-06	0.000159	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—pancreatic cancer	5.92e-06	0.000158	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RB1—pancreatic cancer	5.86e-06	0.000156	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CD—pancreatic cancer	5.86e-06	0.000156	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.83e-06	0.000155	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	5.76e-06	0.000153	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—pancreatic cancer	5.72e-06	0.000152	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TYMS—pancreatic cancer	5.66e-06	0.000151	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TYMS—pancreatic cancer	5.63e-06	0.00015	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—APOE—pancreatic cancer	5.59e-06	0.000149	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.59e-06	0.000149	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	5.48e-06	0.000146	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—pancreatic cancer	5.37e-06	0.000143	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—pancreatic cancer	5.32e-06	0.000142	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TYMS—pancreatic cancer	5.29e-06	0.000141	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—pancreatic cancer	5.29e-06	0.000141	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—pancreatic cancer	5.15e-06	0.000137	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—pancreatic cancer	5.11e-06	0.000136	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CB—pancreatic cancer	5.1e-06	0.000136	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—pancreatic cancer	5.08e-06	0.000135	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—pancreatic cancer	5.06e-06	0.000135	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CG—pancreatic cancer	5.05e-06	0.000134	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—pancreatic cancer	5.04e-06	0.000134	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	5.03e-06	0.000134	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—pancreatic cancer	4.87e-06	0.00013	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—pancreatic cancer	4.86e-06	0.00013	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CD44—pancreatic cancer	4.79e-06	0.000128	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	4.69e-06	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.67e-06	0.000124	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOE—pancreatic cancer	4.61e-06	0.000123	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GCG—pancreatic cancer	4.59e-06	0.000122	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOE—pancreatic cancer	4.58e-06	0.000122	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—pancreatic cancer	4.54e-06	0.000121	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.47e-06	0.000119	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CD—pancreatic cancer	4.44e-06	0.000118	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—pancreatic cancer	4.41e-06	0.000118	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—pancreatic cancer	4.37e-06	0.000116	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—pancreatic cancer	4.35e-06	0.000116	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—pancreatic cancer	4.35e-06	0.000116	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—STK11—pancreatic cancer	4.31e-06	0.000115	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOE—pancreatic cancer	4.3e-06	0.000115	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—pancreatic cancer	4.2e-06	0.000112	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CG—pancreatic cancer	4.16e-06	0.000111	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CG—pancreatic cancer	4.13e-06	0.00011	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—pancreatic cancer	4.11e-06	0.00011	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—pancreatic cancer	4.07e-06	0.000109	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.07e-06	0.000108	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	4.04e-06	0.000108	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—pancreatic cancer	4.01e-06	0.000107	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—pancreatic cancer	3.99e-06	0.000106	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—pancreatic cancer	3.9e-06	0.000104	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CG—pancreatic cancer	3.88e-06	0.000103	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CB—pancreatic cancer	3.87e-06	0.000103	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—pancreatic cancer	3.83e-06	0.000102	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—pancreatic cancer	3.75e-06	9.99e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CD—pancreatic cancer	3.65e-06	9.74e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—pancreatic cancer	3.64e-06	9.7e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CD—pancreatic cancer	3.63e-06	9.68e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—pancreatic cancer	3.49e-06	9.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.43e-06	9.14e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CD—pancreatic cancer	3.42e-06	9.1e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PRSS1—pancreatic cancer	3.34e-06	8.91e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—pancreatic cancer	3.34e-06	8.91e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.19e-06	8.49e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CB—pancreatic cancer	3.19e-06	8.49e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CB—pancreatic cancer	3.17e-06	8.43e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—pancreatic cancer	3.16e-06	8.41e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—pancreatic cancer	3.14e-06	8.36e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—pancreatic cancer	3.11e-06	8.29e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.1e-06	8.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.07e-06	8.18e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOE—pancreatic cancer	3.02e-06	8.04e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.99e-06	7.97e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—pancreatic cancer	2.99e-06	7.97e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CB—pancreatic cancer	2.98e-06	7.93e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—pancreatic cancer	2.95e-06	7.86e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ARG2—pancreatic cancer	2.9e-06	7.72e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—pancreatic cancer	2.87e-06	7.63e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.78e-06	7.39e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—pancreatic cancer	2.75e-06	7.33e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—pancreatic cancer	2.74e-06	7.29e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CG—pancreatic cancer	2.72e-06	7.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.7e-06	7.2e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—pancreatic cancer	2.63e-06	7e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—pancreatic cancer	2.57e-06	6.85e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—pancreatic cancer	2.54e-06	6.77e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TYMP—pancreatic cancer	2.53e-06	6.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.49e-06	6.63e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.48e-06	6.61e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.43e-06	6.48e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CD—pancreatic cancer	2.39e-06	6.38e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—pancreatic cancer	2.36e-06	6.28e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.32e-06	6.17e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.3e-06	6.12e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.11e-06	5.62e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CB—pancreatic cancer	2.09e-06	5.56e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—pancreatic cancer	2.07e-06	5.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.04e-06	5.44e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.04e-06	5.44e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—DPYD—pancreatic cancer	2.01e-06	5.35e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—pancreatic cancer	1.94e-06	5.17e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—pancreatic cancer	1.93e-06	5.14e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—pancreatic cancer	1.93e-06	5.13e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.91e-06	5.08e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—pancreatic cancer	1.81e-06	4.83e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—pancreatic cancer	1.8e-06	4.81e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.72e-06	4.59e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—pancreatic cancer	1.59e-06	4.23e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—pancreatic cancer	1.58e-06	4.2e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—pancreatic cancer	1.48e-06	3.95e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CD44—pancreatic cancer	1.48e-06	3.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GCG—pancreatic cancer	1.42e-06	3.77e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—STK11—pancreatic cancer	1.33e-06	3.55e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—pancreatic cancer	1.27e-06	3.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.15e-06	3.05e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—pancreatic cancer	1.04e-06	2.77e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOE—pancreatic cancer	9.31e-07	2.48e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	8.41e-07	2.24e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—pancreatic cancer	8.11e-07	2.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	7.39e-07	1.97e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	6.44e-07	1.72e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—pancreatic cancer	6.38e-07	1.7e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—pancreatic cancer	5.57e-07	1.48e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.93e-07	1.05e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—pancreatic cancer	3.21e-07	8.55e-06	CbGpPWpGaD
